Aspirin and Normochromic normocytic anaemia - a phase IV clinical study of FDA data

Summary:

Normochromic normocytic anaemia is found among people who take Aspirin, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Aspirin and have Normochromic normocytic anaemia. It is created by eHealthMe based on reports of 543,530 people who have side effects when taking Aspirin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

543,530 people reported to have side effects when taking Aspirin.
Among them, 246 people (0.05%) have Normochromic normocytic anaemia.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 552,868 Aspirin users for its effectiveness, alternative drugs and more.

What is Normochromic normocytic anaemia?

Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits) is found to be associated with 1,128 drugs and 623 conditions by eHealthMe.

Number of Aspirin and Normochromic normocytic anaemia reports submitted per year:

Could Aspirin cause Normochromic normocytic anaemia?

* Approximation only. Some reports may have incomplete information.

Do you take Aspirin and have Normochromic normocytic anaemia?

Check whether Normochromic normocytic anaemia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .

Related studies

How severe was Normochromic normocytic anaemia and when was it recovered:

Normochromic normocytic anaemia in Aspirin

Expand to all the drugs that have ingredients of aspirin:

Normochromic normocytic anaemia and drugs with ingredients of aspirin (288 reports)

Alternative drugs to, pros and cons of Aspirin:

Aspirin (552,868 reports)

Common Aspirin side effects:

Fatigue (feeling of tiredness): 37,295 reports
Breathing difficulty: 30,192 reports
Diarrhea: 28,557 reports
Weakness: 26,881 reports
Dizziness: 26,541 reports
Drug ineffective: 22,961 reports
Pain: 22,318 reports

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Normochromic normocytic anaemia treatments and more:

Normochromic normocytic anaemia (4,034 reports)

COVID vaccines that are related to Normochromic normocytic anaemia:

Common drugs associated with Normochromic normocytic anaemia:

All the drugs that are associated with Normochromic normocytic anaemia:

Normochromic normocytic anaemia (1,128 drugs)

Common conditions associated with Normochromic normocytic anaemia:

High blood pressure: 328 reports
Osteoporosis: 161 reports
Atrial fibrillation/flutter: 147 reports
Depression: 145 reports
Rheumatoid arthritis: 136 reports
Pain: 122 reports

All the conditions that are associated with Normochromic normocytic anaemia:

Normochromic normocytic anaemia (623 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aspirin (the active ingredients of Aspirin) and Aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.